详细信息
背景信息
What is this antibody validated in? Anti-CD20 antibody [L26] (ab9475) is a mouse monoclonal antibody and is validated for use in Immunohistochemistry (IHC-P) in Human samples. Trusted by the scientific community Anti-CD20 [L26] (ab9475) was first used in a scientific publication in 2002 and has been cited over 70 times in peer-reviewed journals. Reviewed by scientists Anti-CD20 [L26] (ab9475) has over 5 independent reviews from customers.
文献引用 (76)
Mucin 16-Directed Therapy in Pediatric Sarcomas: Case Evidence of Ubamatamab Efficacy in Epithelioid Sarcoma and Its Implications for Other Sarcoma Subtypes.
针对儿童肉瘤的 Mucin 16 靶向治疗:Ubamatamab 在上皮样肉瘤中的疗效病例证据及其对其他肉瘤亚型的意义
Pan-immune-inflammation value predicts immunotherapy response and reflects local antitumor immune response in rectal cancer
泛免疫炎症值可预测免疫治疗反应并反映直肠癌局部抗肿瘤免疫反应
The Prognostic Role of Tertiary Lymphoid Structures and Immune Microenvironment Signatures in Early-Stage EGFR-Mutant Lung Adenocarcinoma.
三级淋巴结构和免疫微环境特征在早期 EGFR 突变肺腺癌中的预后作用
Mercury Can Bond to α-Carbon of Curcumin Increasing Stability in Aqueous Medium and Demonstrated Selective Cytotoxicity against Acute Leukemia.
汞可与姜黄素的α-碳结合,提高其在水性介质中的稳定性,并表现出对急性白血病的选择性细胞毒性
B cells enhance IL-1 beta driven invasiveness in triple negative breast cancer
细胞增强 IL-1β 驱动的三阴性乳腺癌侵袭性
Response‑adapted involved site radiation therapy for hepatic marginal zone B‑cell lymphoma: A case report
肝边缘区 B 细胞淋巴瘤的适应性受累部位放射治疗:病例报告
Intestinal CXCR6+ ILC3s migrate to the kidney and exacerbate renal fibrosis via IL-23 receptor signaling enhanced by PD-1 expression
肠道CXCR6+ ILC3细胞迁移至肾脏,并通过PD-1表达增强的IL-23受体信号通路加剧肾纤维化。
Single-cell and spatial transcriptome analyses reveal tertiary lymphoid structures linked to tumour progression and immunotherapy response in nasopharyngeal carcinoma
单细胞和空间转录组分析揭示了与鼻咽癌肿瘤进展和免疫治疗反应相关的三级淋巴结构
An immune cell map of human lung adenocarcinoma development reveals an anti-tumoral role of the Tfh-dependent tertiary lymphoid structure
人类肺腺癌发展过程中的免疫细胞图谱揭示了Tfh依赖性三级淋巴结构在抗肿瘤中的作用。
Inhibiting PLA2G7 reverses the immunosuppressive function of intratumoral macrophages and augments immunotherapy response in hepatocellular carcinoma
抑制PLA2G7可逆转肿瘤内巨噬细胞的免疫抑制功能,并增强肝细胞癌的免疫治疗反应。
- 1
- 2
- 3
- 4
- 5
- 6
- 8